Advent Trims Interest in Cohance, a CDMO
22 Sep 2025
US$ 20.00
Advent International (Advent) has sold an 8.9% stake in Cohance Lifesciences Ltd (Cohance) and clocked 30.9 bn rupees...
Related Publications
Subscribers’ Weekly for the week ending 26 Sep 2025...
Chiratae Ventures has raised US$150 m for the second closing of its Chiratae Ventures India Fund V...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.